[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (7): 777-783.doi: 10.3736/jcim20120708

• Original Experimental Research • Previous Articles     Next Articles

Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone

Feng Xin-ying1,2,Zhu Min3,4,Zhang Qi-qi1,Chen Yi-ping1,Li Wen-wei1,3()   

  1. 1. Laboratory of Neurophysiology and Neurophathology, Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    2. Quality Control Department of Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Shanghai 201206, China
    3. Institute of Neurology, Fudan University, Shanghai 200040, China
    4. State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China
  • Received:2012-03-15 Accepted:2012-03-31 Online:2012-07-20 Published:2018-07-15
  • Contact: Wen-wei Li E-mail:wenweili2000@yahoo.com.cn

Objective: To observe the protective effects of echinacoside on rotenone-induced damages in rats.
Methods: Healthy male Sprague-Dawley rats, weighing from 200 to 220 g, were randomly divided into five groups with 20 rats in each group: control group, rotenone group and echinacoside groups of low, medium and high doses (20, 40 and 80 mg/(kg·d)). Rats in the rotenone group were injected intraperitoneally for four weeks with rotenone (2.75 mg/(kg·d)), dissolved into dimethyl sulfoxide; rats in the control group were injected intraperitoneally with dimethyl sulfoxide daily, and rats in the echinacoside groups received daily intraperitoneal injection of rotenone along with echinacoside gastric perfusion for four weeks. Modified neurological severity score was used to evaluate neurobehavior of the animals; dopaminergic neurons in substantia nigra were observed by immunochemical method and dopamine concentration in striatum was determined by a fluorescence spectrophotometer. Biomarkers of liver and kidney damage were also measured.
Results: In the rotenone group, the rats suffered from severe neurological disability (P<0.01), and the number of dopaminergic neurons in substantia nigra and dopamine concentration in striatum were decreased (P<0.05) compared with the normal control group; levels of the biomarkers for evaluating liver and kidney damage were increased (P<0.05). In the echinacoside groups, the neurological disability and the loss of dopaminergic neurons in substantia nigra were suppressed and dopamine concentrations in striatum were increased (P<0.05), but the liver and kidney damage was not improved (P>0.05).
Conclusion: Rotenone causes severe damages to dopaminergic neurons, liver and kidney in rats and echinacoside selectively reverses dopaminergic neuronal injury.

Key words: Parkinson disease, rotenone, echinacoside, liver injury, kidney injury, dopaminergic neurons, rats

"

Group n mNSS
Normal control 14 0
Rotenone 14 12.86±2.25**
ECH (20 mg/(kg·d), ip)
plus rotenone
14 8.07±1.73**△
ECH (40 mg/(kg·d), ip)
plus rotenone
14 5.79±1.63**△▲
ECH (80 mg/(kg·d), ip)
plus rotenone
14 3.57±1.65**△▲□

"

Group n ALT AST
Normal control 14 31.75±8.59 85.76±16.41
Rotenone 14 84.57±14.14* 202.74±28.16*
ECH (20 mg/(kg·d), ip) plus rotenone 14 81.45±13.47* 198.62±29.82*
ECH (40 mg/(kg·d), ip) plus rotenone 14 82.95±14.55* 204.35±31.01*
ECH (80 mg/(kg·d), ip) plus rotenone 14 79.35±12.03* 201.16±28.29*

"

Group n Creatinine (μmol/L) Blood urea nitrogen (mmol/L)
Normal control 14 31.32±6.43 4.93±0.85
Rotenone 14 67.21±10.39* 18.81±2.11*
ECH (20 mg/(kg·d), ip) plus rotenone 14 65.78±11.81* 18.35±2.51*
ECH (40 mg/(kg·d), ip) plus rotenone 14 62.38±12.21* 17.55±1.87*
ECH (80 mg/(kg·d), ip) plus rotenone 14 63.99±11.76* 17.36±1.79*

Figure 1

Effects of echinacoside on dopaminergic neurons in substantia nigra of rats exposed to rotenone observed by immunochemical method (Light microscopy, ×100) A: Normal control group; B: Rotenone group; C: Echinacoside (40 mg/(kg·d), ip) plus rotenone group; D: Echinacoside (80 mg/(kg·d), ip) plus rotenone group. ip: intraperitoneal injection."

"

Group n Number of dopaminergic neurons
Normal control 7 118.85±13.18
Rotenone 7 61.29±9.92*
ECH (20 mg/(kg·d), ip) plus rotenone 7 86.71±11.21
ECH (40 mg/(kg·d), ip) plus rotenone 7 96.57±13.43
ECH (80 mg/(kg·d), ip) plus rotenone 7 104.42±11.25

Figure 2

Effects of echinacoside on expression of tyrosine hydroxylase in striatum of rats exposed to rotenone observed by immunochemical method (Light microscopy, ×50) A: Normal control group; B: Rotenone group; C: Echinacoside (80 mg/(kg·d), ip) plus rotenone group."

"

Group n Dopamine concentration (μg/g)
Normal control 7 9.39±1.23
Rotenone 7 5.57±0.71*
ECH (20 mg/(kg·d), ip) plus rotenone 7 8.23±0.91
ECH (40 mg/(kg·d), ip) plus rotenone 7 8.79±0.79
ECH (80 mg/(kg·d), ip) plus rotenone 7 8.83±0.87
[1] Zhao X, Pu XP, Geng XC . Effects of echinacoside on protein expression from substantia nigra and striatal tissue in mouse MPTP model of Parkinsons disease by using 2-dimensional electrophoresis analysis[J]. Zhongguo Yao Li Xue Tong Bao, 2008,24(1):28-32
doi: 10.3321/j.issn:1001-1978.2008.01.008
赵欣, 蒲小平, 耿兴超 . 松果菊苷对帕金森病模型小鼠黑质纹状体蛋白表达影响的双向电泳分析[J]. 中国药理学通报, 2008,24(1):28-32
doi: 10.3321/j.issn:1001-1978.2008.01.008
[2] Zhao Q, Gao J, Li W, Cai D . Neurotrophic and neurorescue effects of echinacoside in the subacute MPTP mouse model of Parkinson’s disease[J]. Brain Res, 2010, 1346: 224-236
doi: 10.1016/j.brainres.2010.05.018
[3] Dauer W, Przedborski S . Parkinson’s disease: mechanisms and models[J]. Neuron, 2003,39(6):889-909
doi: 10.1016/S0896-6273(03)00568-3
[4] Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT . A highly reproducible rotenone model of Parkinson’s disease[J]. Neurobiol Dis, 2009,34(2):279-290
doi: 10.1016/j.nbd.2009.01.016 pmid: 19385059
[5] Lapointe N, St-Hilaire M, Martinoli MG, Blanchet J, Gould P, Rouillard C, Cicchetti F . Rotenone induces non-specific central nervous system and systemic toxicity[J]. FASEB J, 2004,18(6):717-719
doi: 10.1096/fj.03-0677fje pmid: 14766796
[6] Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E . An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits[J]. J Neurotrauma, 1996,13(10):557-568
doi: 10.1089/neu.1996.13.557
[7] Yao QH, Gao GD . Inosine is neuroprective against MPTP-induced Parkinson’s disease in C57BL mice[J]. Di Si Jun Yi Da Xue Xue Bao, 2005,26(2):141-145
姚庆和, 高国栋 . 肌苷对帕金森病小鼠模型的神经保护作用[J]. 第四军医大学学报, 2005,26(2):141-145
[8] Zhan QJ, Zhang YY, Huang WY . Traditional Chinese medicine in treatment of Parkinson’s disease[J]. J Chin Integr Med, 2004,2(1):75-77
张秋娟, 张云云, 黄文燕 . 中医药治疗帕金森病的思路与方法[J]. 中西医结合学报, 2004,2(1):75-77
[9] He WJ, Fang TH, Tu PF . Research progress on pharmacological activities of echinacoside[J]. Zhongguo Zhong Yao Za Zhi, 2009,34(4):476-479
何文君, 方泰惠, 屠鹏飞 . 松果菊苷的药理研究进展[J]. 中国中药杂志, 2009,34(4):476-479
[10] An CN, Zhang HN, Pu XP. Research progress on neuropharmacological activities of Cistanche. Zhongguo Yao Xue Za Zhi. 2011; 46(12): 887-890. Chinese
安春娜, 张宏宁, 蒲小平 . 肉苁蓉的神经药理学研究进展[J]. 中国药学杂志, 2011,46(12):887-890
[11] Langston JW, Ballard P, Tetrud JW, Irwin I . Chronic Parkinsonism in humans due to a product of meperidine-analog synjournal[J]. Science, 1983,219(4587):979-980
doi: 10.1126/science.6823561
[12] von Bohlen und Halbach O, Schober A, Krieglstein K . Genes, proteins, and neurotoxins involved in Parkinson’s disease[J]. Prog Neurobiol, 2004,73(3):151-177
doi: 10.1016/j.pneurobio.2004.05.002 pmid: 15236834
[13] Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC . Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors[J]. Nature, 1984,311(5985):467-469
doi: 10.1038/311467a0
[14] Javitch JA , D’Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity[J]. Proc Natl Acad Sci U S A, 1985,82(7):2173-2177
doi: 10.1073/pnas.82.7.2173
[15] Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Counsell C, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A . Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study[J]. Occup Environ Med, 2007,64(10):666-672
doi: 10.1136/oem.2006.027003 pmid: 2078401
[16] Greenamyre JT, Betarbet R, Sherer TB . The rotenone model of Parkinson’s disease: genes, environment and mitochondria[J]. Parkinsonism Relat Disord, 2003,9(Suppl 2):S59-S64
doi: 10.1016/S1353-8020(03)00023-3
[17] Xiong Q, Hase K, Tezuka Y, Namba T, Kadota S . Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury[J]. Life Sci, 1999,65(4):421-430
doi: 10.1016/S0024-3205(99)00263-5 pmid: 10421428
[18] Wu Y, Li L, Wen T, Li YQ . Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats[J]. Toxicology, 2007,232(1-2):50-56
doi: 10.1016/j.tox.2006.12.013 pmid: 17222497
[19] Wu Y, Xu GL, Lou M, Zheng Z . The protective effect of echinacoside on acute liver injury in rats[J]. Wei Chang Bing Xue He Gan Bing Xue Za Zhi, 2008,17(5):410-412
吴煜, 许桂林, 楼敏, 曾珍 . 松果菊苷对大鼠急性肝损伤的保护作用[J]. 胃肠病学和肝病学杂志, 2008,17(5):410-412
[1] Na Wu , Lu Song , Xin-xin Yang, Jiang-lei Wei , Zhen-guo Liu. Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1018-1024.
[2] Lawrence A. Olatunji, Taofeek O. Usman, Joseph O. Adebayo, Victoria A. Olatunji . Effects of aqueous extract of Hibiscus sabdariffa on renal Na+-K+-ATPase and Ca2+-Mg2+-ATPase activities in Wistar rats. Journal of Chinese Integrative Medicine, 2012, 10(9): 1049-1055.
[3] Dhirender Kaushik, Ajay Kumar, Pawan Kaushik, Avatar C. Rana. Anticonvulsant activity of alcoholic extract of bark of Pinus roxburghii Sarg. Journal of Chinese Integrative Medicine, 2012, 10(9): 1056-1060.
[4] Chan Chen, Chang-xun Chen, Xi-min Wu, Rui Wang, Yi-ming Li. Effects of extracts of Radix Scrophulariae on blood pressure in spontaneously hypertensive rats and the underlying mechanisms. Journal of Chinese Integrative Medicine, 2012, 10(9): 1009-1017.
[5] Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048.
[6] Karuna A. Talpate, Uma A. Bhosale, Mandar R. Zambare. Clitorea ternatea, a herb from Indian folklore, improves streptozotocin-induced diabetes and diabetes-induced cognitive decline in rats. Journal of Chinese Integrative Medicine, 2012, 10(8): 939-947.
[7] Samuel Joshua Pragasam, Vachana Murunikara, Evan Prince Sabina, Mahaboobkhan Rasool. Antiperoxidative potential of p-coumaric acid, a common dietary phenol, in adjuvant-induced arthritis in rats. Journal of Chinese Integrative Medicine, 2012, 10(8): 932-938.
[8] Zi-hui Li, Jian Wang, Rong-lin Cai, You-wen Wang, Jian-peng Hu. Establishment and evaluation of a rat model of ulcerative colitis with syndrome of dampness stagnancy due to spleen deficiency. Journal of Chinese Integrative Medicine, 2012, 10(8): 918-924.
[9] Meng Li, Ling Hu, Rong-lin Cai, Zi-jian Wu, Ke-ming Wang. Effects of electro-acupuncture at PC6 and BL15 on nerve electrical activity in spinal dorsal root and norepinephrine and dopamine contents in paraventricular nucleus of hypothalamus in rats with acute myocardial ischemia. Journal of Chinese Integrative Medicine, 2012, 10(8): 874-879.
[10] Xin-min Li, Hui Chen, Yan-yan Ren, Yan-li Lu. Effects of Chinese herbal medicine Xifeng Capsule on multidrug resistance-associated protein 1 expression in hippocampus and cortex of rats with lithium-pilocarpine-induced epilepsy. Journal of Chinese Integrative Medicine, 2012, 10(8): 911-917.
[11] Hong Wang , Jing-tian Ou , Xin Zhao , Ying Guoz , Hao-ping Mao. Vasodilator effect of oroxylin A on thoracic aorta isolated from rats. Journal of Chinese Integrative Medicine, 2012, 10(8): 880-885.
[12] C. Mouli Kalla, Vijaya Tartte, Dattatreya Rao Sirpurkar. Effectiveness of flavonoid-rich leaf extract of Acalypha indica in reversing experimental myocardial ischemia: biochemical and histopathological evidence. Journal of Chinese Integrative Medicine, 2012, 10(7): 784-792.
[13] Chuan Chen, Hui-ying Chi, Zhi-hua Yu, Jiu-lin Chen . Effects of Chinese herbal medicine Shoushen Granule on telomere length and telomerase activity of peripheral white blood cells and vascular cells in rats with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(6): 667-673.
[14] Hui-qing Zhang , Zi-fei Yin , Jia-yu Sheng , Zhu-qian Jiang , Bao-yu Wu , Yong-hua Su. A comparison study of pharmacokinetics between bufalin-loaded bovine serum albumin nanoparticles and bufalin in rats. Journal of Chinese Integrative Medicine, 2012, 10(6): 674-680.
[15] Ju-yong Wang, Jing Guo, Chang-sheng Dong, Zhan Zheng, Qing Wang. Effects of Feiyanning Decoction, a compound traditional Chinese medicine, on iNOS and COX-2 expressions induced by tumor necrosis factor-α in lung adenocarcinoma cell line. Journal of Chinese Integrative Medicine, 2012, 10(6): 695-700.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278
[an error occurred while processing this directive]